State of Wyoming’s Verve Therapeutics VERV Stock Holding History

State of Wyoming’s Portfolio VERV Stock Details VERV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-12,937	Closed	-$145K	–	2074
2025 Q2	$145K	Buy	+12,937	New	+$73.7K	0.02%	1107
2022 Q3	–	Sell	-121	Closed	-$2K	–	1958
2022 Q2	$2K	Sell	121 -632	-84%	-$9.79K	﹤0.01%	1790
2022 Q1	$17K	Buy	753 +224	+42%	+$6.4K	0.01%	1486
2021 Q4	$20K	Buy	529 +71	+16%	+$2.98K	0.01%	1471
2021 Q3	$22K	Buy	+458	New	+$26.9K	0.01%	925

Other funds holding VERV

GCM

Greenland Capital Management New York $787M AUM 40.68% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

BIG

Brooklyn Investment Group Brooklyn, New York $3.2B AUM 26.32% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

State of Wyoming's VERV Position: Q3 2025 in Review

State of Wyoming sold out of Verve Therapeutics (VERV) in Q3 2025, closing a stake of 12,937 shares — an estimated $145K sold.

State of Wyoming first reported a position in VERV in Q3 2021 and held it in 5 quarters. The position peaked at $145K in Q2 2025. 6 funds tracked by Wall St. Rank hold VERV as of Q3 2025.

State of Wyoming reported no remaining Verve Therapeutics position as of Q3 2025 after selling out during the quarter.
State of Wyoming sold 12,937 Verve Therapeutics shares in Q3 2025, an estimated $145K.
State of Wyoming first reported a position in Verve Therapeutics in Q3 2021 and held it in 5 quarters.
State of Wyoming's Verve Therapeutics position peaked at $145K in Q2 2025.
6 funds tracked by Wall St. Rank held Verve Therapeutics as of Q3 2025.

Based on State of Wyoming's 13F filing for Q3 2025, filed 4 Nov 2025.